Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
Linyu YangKai HuangLijian CaoYue MaSuwen LiJianwu ZhouZhenzhen ZhaoShan WangPublished in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2024)
Our results suggest that TNFAIP3 was first identified as a promising biomarker for immunotherapy and potential molecular target in NB. Besides, the presence of TNFAIP3 within TAMs may offer a novel therapeutic strategy for NB.